41 related articles for article (PubMed ID: 28337834)
21. Phenotypic spectrum of Costello syndrome individuals harboring the rare HRAS mutation p.Gly13Asp.
Bertola D; Buscarilli M; Stabley DL; Baker L; Doyle D; Bartholomew DW; Sol-Church K; Gripp KW
Am J Med Genet A; 2017 May; 173(5):1309-1318. PubMed ID: 28371260
[TBL] [Abstract][Full Text] [Related]
22. An attenuated phenotype of Costello syndrome in three unrelated individuals with a HRAS c.179G>A (p.Gly60Asp) mutation correlates with uncommon functional consequences.
Gripp KW; Sol-Church K; Smpokou P; Graham GE; Stevenson DA; Hanson H; Viskochil DH; Baker LC; Russo B; Gardner N; Stabley DL; Kolbe V; Rosenberger G
Am J Med Genet A; 2015 Sep; 167A(9):2085-97. PubMed ID: 25914166
[TBL] [Abstract][Full Text] [Related]
23. Functional analysis of a duplication (p.E63_D69dup) in the switch II region of HRAS: new aspects of the molecular pathogenesis underlying Costello syndrome.
Lorenz S; Lissewski C; Simsek-Kiper PO; Alanay Y; Boduroglu K; Zenker M; Rosenberger G
Hum Mol Genet; 2013 Apr; 22(8):1643-53. PubMed ID: 23335589
[TBL] [Abstract][Full Text] [Related]
24. Phenotypic analysis of individuals with Costello syndrome due to HRAS p.G13C.
Gripp KW; Hopkins E; Sol-Church K; Stabley DL; Axelrad ME; Doyle D; Dobyns WB; Hudson C; Johnson J; Tenconi R; Graham GE; Sousa AB; Heller R; Piccione M; Corsello G; Herman GE; Tartaglia M; Lin AE
Am J Med Genet A; 2011 Apr; 155A(4):706-16. PubMed ID: 21438134
[TBL] [Abstract][Full Text] [Related]
25. Costello syndrome associated with novel germline HRAS mutations: an attenuated phenotype?
Gripp KW; Innes AM; Axelrad ME; Gillan TL; Parboosingh JS; Davies C; Leonard NJ; Lapointe M; Doyle D; Catalano S; Nicholson L; Stabley DL; Sol-Church K
Am J Med Genet A; 2008 Mar; 146A(6):683-90. PubMed ID: 18247425
[TBL] [Abstract][Full Text] [Related]
26. HRAS and the Costello syndrome.
Rauen KA
Clin Genet; 2007 Feb; 71(2):101-8. PubMed ID: 17250658
[TBL] [Abstract][Full Text] [Related]
27. Costello syndrome with special cutaneous manifestations and HRAS G12D mutation: A case report and literature review.
Qian W; Zhang M; Huang H; Chen Y; Park G; Zeng N; Li Y; Lu Q; Luo D
Mol Genet Genomic Med; 2021 Jun; 9(6):e1690. PubMed ID: 33932139
[TBL] [Abstract][Full Text] [Related]
28. High incidence of progressive postnatal cerebellar enlargement in Costello syndrome: brain overgrowth associated with HRAS mutations as the likely cause of structural brain and spinal cord abnormalities.
Gripp KW; Hopkins E; Doyle D; Dobyns WB
Am J Med Genet A; 2010 May; 152A(5):1161-8. PubMed ID: 20425820
[TBL] [Abstract][Full Text] [Related]
29. Noonan, Costello and cardio-facio-cutaneous syndromes: dysregulation of the Ras-MAPK pathway.
Tidyman WE; Rauen KA
Expert Rev Mol Med; 2008 Dec; 10():e37. PubMed ID: 19063751
[TBL] [Abstract][Full Text] [Related]
30. Genetic and pathogenetic aspects of Noonan syndrome and related disorders.
Zenker M
Horm Res; 2009 Dec; 72 Suppl 2():57-63. PubMed ID: 20029240
[TBL] [Abstract][Full Text] [Related]
31. A diagnostic approach to syndromic retinal dystrophies with intellectual disability.
Yang XR; Benson MD; MacDonald IM; Innes AM
Am J Med Genet C Semin Med Genet; 2020 Sep; 184(3):538-570. PubMed ID: 32918368
[TBL] [Abstract][Full Text] [Related]
32. Multidisciplinary Management of Costello Syndrome: Current Perspectives.
Leoni C; Viscogliosi G; Tartaglia M; Aoki Y; Zampino G
J Multidiscip Healthc; 2022; 15():1277-1296. PubMed ID: 35677617
[TBL] [Abstract][Full Text] [Related]
33. Retinal dystrophy in two boys with Costello syndrome due to the HRAS p.Gly13Cys mutation.
Pierpont ME; Richards M; Engel WK; Mendelsohn NJ; Summers CG
Am J Med Genet A; 2017 May; 173(5):1342-1347. PubMed ID: 28337834
[TBL] [Abstract][Full Text] [Related]
34. Costello syndrome: a Ras/mitogen activated protein kinase pathway syndrome (rasopathy) resulting from HRAS germline mutations.
Gripp KW; Lin AE
Genet Med; 2012 Mar; 14(3):285-92. PubMed ID: 22261753
[TBL] [Abstract][Full Text] [Related]
35. Fatal congenital hypertrophic cardiomyopathy and a pancreatic nodule morphologically identical to focal lesion of congenital hyperinsulinism in an infant with costello syndrome: case report and review of the literature.
Sheffield BS; Yip S; Ruchelli ED; Dunham CP; Sherwin E; Brooks PA; Sur A; Singh A; Human DG; Patel MS; Lee AF
Pediatr Dev Pathol; 2015; 18(3):237-44. PubMed ID: 25668678
[TBL] [Abstract][Full Text] [Related]
36. Neurocognitive, adaptive, and behavioral functioning of individuals with Costello syndrome: a review.
Axelrad ME; Schwartz DD; Katzenstein JM; Hopkins E; Gripp KW
Am J Med Genet C Semin Med Genet; 2011 May; 157C(2):115-22. PubMed ID: 21495179
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
